(NASDAQ:AIKI)
seekingalpha.com
news
2022-06-03 20:41:39

Alkido Pharma (NASDAQ:AIKI) stated Friday it has received Board's approval to execute a 1-for-17 reverse stock split.
The move is aligned to increase the market price per share of the company's stock to come into compliance with Nasdaq's listing requirements.
AIKI stock will begin trading on post-split basis on June 7, 2022. This will reduce the company's outstanding common stock from approximately 89.29M shares to approximately 5.25M shares.
Stock is down 9% in after hours trading.

Earlier: AI
